Impulse Dynamics
Impulse Dynamics is a privately held medical device company that develops the Optimizer Smart Mini, an implantable device delivering Cardiac Contractility Modulation (CCM) therapy to NYHA Class III heart failure patients not eligible for cardiac resynchronization therapy. It sells direct to hospitals and electrophysiologists across 40+ countries.
- Company typePrivate
- Founded1998
- HeadquartersMarlton, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Impulse Dynamics does
Impulse Dynamics is a privately held medical device company founded in 1997 by Professor Shlomo Ben-Haim (who holds 550+ patents) and headquartered in Marlton, NJ, with international commercial operations based in Frankfurt, Germany. The company develops and commercializes Cardiac Contractility Modulation (CCM) therapy, delivered via its Optimizer Smart Mini — a minimally invasive implantable pulse generator roughly the size of a pacemaker that delivers non-excitatory electrical signals during the heart's absolute refractory period to strengthen cardiac contractility without affecting rhythm. The device targets NYHA Class III heart failure patients with left ventricular ejection fraction of 25-45% who remain symptomatic despite guideline-directed medical therapy and are not candidates for cardiac resynchronization therapy (CRT) — a population representing roughly 70% of NYHA Class III patients who previously had no FDA-approved device-based treatment option.
The business model is direct sale of the Optimizer Smart Mini hardware system (and accessories such as Vesta and Guardio chargers) to hospitals and electrophysiologists, supported by an enterprise field sales motion, physician training programs, and a dedicated reimbursement support function that navigates Medicare and commercial payor coverage. The company has built a broad clinical evidence base across 80+ peer-reviewed publications and randomized trials (FIX-HF-5, FIX-HF-5C, FIX-HF-5C2), with over 12,000 patients implanted across 40+ countries. Key regulatory milestones include FDA PMA approval of the Optimizer Smart (March 2019), Optimizer Smart Mini approval (July 2021), CE Mark (October 2016), and most significantly a CMS National Coverage Determination issued October 2025 covering all FDA-indicated patients over age 18.
Impulse Dynamics has raised over $500M cumulatively across multiple private rounds from institutional medtech-focused investors including Perceptive Advisors, Redmile Group, Braidwell, Sands Capital, Alger, and Hobart Healthcare. The most recent $158M round closed in December 2025 to fund commercialization, clinical trials (INTEGRA-D and AIM HIGHer), and pipeline development of the investigational CCM-D (CCM-Defibrillator) combined system. The executive team was substantially rebuilt in 2024-2026 with senior operators from Medtronic, Boston Scientific, Biosense Webster, St. Jude Medical, and Inspire Medical Systems, suggesting a positioning toward a future IPO or strategic transaction.
Impulse Dynamics firmographics
Firmographics- Name
- Impulse Dynamics
- Legal name
- Impulse Dynamics N.V.
- Website
- https://impulse-dynamics.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Impulse Dynamics is a privately held medical device company that develops the Optimizer Smart Mini, an implantable device delivering Cardiac Contractility Modulation (CCM) therapy to NYHA Class III heart failure patients not eligible for cardiac resynchronization therapy. It sells direct to hospitals and electrophysiologists across 40+ countries.
- Ownership category
- akta.pro rank
Impulse Dynamics industry classification
Industry- Product category
- Implantable Cardiac Devices / Cardiac Rhythm Management
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
- akta.pro secondary industries
- Cardiac Rhythm Management (Pacemakers, ICDs, CRT) (HLAHAFAC), Heart Failure & Transplant Cardiology (HLAKABAD)
Keywords
Where Impulse Dynamics is headquartered
LocationHeadquarters
- HQ city
- Marlton
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Impulse Dynamics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Device Sales: Impulse Dynamics generates revenue through the sale of its implantable medical devices - the Optimizer Smart and Optimizer Smart Mini systems. These devices are sold to hospitals and physicians who implant them in heart failure patients. The company also sells accessories including chargers (Vesta and Guardio chargers) and programmers.
- Provider Support Services: The company provides reimbursement support services for trained physicians and facilities, including coding guidance, payment analysis, and patient access program enrollment assistance. While primarily a support function, this enables the core device revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical device with complex reimbursement pathways - pricing not publicly available |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Impulse Dynamics product offering
Product offeringCore offering
Impulse Dynamics develops, manufactures, and commercializes the Optimizer Smart Mini implantable pulse generator, which delivers proprietary Cardiac Contractility Modulation (CCM) therapy to improve symptoms and quality of life in NYHA Class III heart failure patients who are not candidates for cardiac resynchronization therapy. The system is sold to hospitals and trained cardiac electrophysiologists and is supported by external chargers (Vesta, Guardio) and programmers, plus physician training and reimbursement support services.
Differentiator
Problem solved
Functional benefit
Products and services
- Optimizer Smart Mini System Minimally invasive implantable pulse generator that delivers Cardiac Contractility Modulation (CCM) therapy to NYHA Class III heart failure patients with LVEF 25-45% who remain symptomatic despite guideline-directed medical therapy and are not candidates for cardiac resynchronization therapy (CRT). Delivers precisely timed non-excitatory electrical pulses during 5-7 hours of daily therapy, with one hour of weekly charging and an expected 20-year battery life. Sold to hospitals and trained cardiac electrophysiologists and heart failure specialists.
- Optimizer Smart System Original-generation implantable pulse generator delivering CCM therapy for NYHA Class III heart failure patients with LVEF 25-45% who are not indicated for CRT. First FDA-approved device for delivery of CCM therapy in the United States and the first to attain FDA Breakthrough Device status. Sold to hospitals and trained cardiac electrophysiologists.
- Optimizer INTEGRA CCM-D HF System Investigational combined CCM and defibrillation (CCM-D) implantable system designed to deliver both Cardiac Contractility Modulation therapy and ICD therapy for heart failure patients who require both modalities. Targeted at patients indicated for both CCM therapy and an implantable cardioverter defibrillator.
- Vesta and Guardio Chargers External transcutaneous charging systems (Vesta and Guardio) used to recharge the Optimizer Smart Mini implanted pulse generator on a weekly basis. Sold to hospitals and patients as accessories to the Optimizer Smart Mini system.
- Optimizer Programmer Proprietary programmer device used by clinicians to interrogate, configure, and program the implanted Optimizer Smart and Optimizer Smart Mini devices during and after implantation. Sold to hospitals and implanting physicians.
Quantifiable outcome
- Patients walk on average 33.7 meters further than control group during 6-minute hall walk test
- +6 more outcomes
Companies that use Impulse Dynamics
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Impulse Dynamics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Impulse Dynamics partnerships and signals
Strategic signalScale indicators9 records
Recent moves6 records
Expansion highlights5 records
Impulse Dynamics competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Global leader in cardiac rhythm management with CRT-D, ICD, and heart failure device franchises. Competes with Impulse Dynamics for implant slots and electrophysiology mind-share, and several Impulse Dynamics executives (e.g., COO Noel Colón) are former Medtronic CRM leaders.
- Abbott: Through its St. Jude Medical acquisition, Abbott is a leading CRM and HF device player offering CRT, ICDs, and the CardioMEMS HF System. It competes with Impulse Dynamics in the broader HF device category and for hospital contracting leverage.
- Boston Scientific: Major CRM and heart failure device competitor with CRT-D, ICDs, and the WATCHMAN franchise. Impulse Dynamics CEO Jason Spees is a former Boston Scientific VP of Sales, and the company is a significant account-level competitor for HF device implant share.
- Edwards Lifesciences: Global structural heart and heart failure therapy leader, including transcatheter heart valves and critical care monitoring. Comparable as a scaled, profitable heart failure franchise and as a strategic acquirer of novel HF device technologies.
- ZOLL Medical: Cardiac and resuscitation device company (now part of Asahi Kasei), with defibrillation, wearable cardioverter defibrillators, and HF-adjacent products. A historical Impulse Dynamics investor (2019 round) and a peer in the broader cardiac device ecosystem.
Direct peers
- Biotronik: Privately held German CRM and electrophysiology device company offering pacemakers, ICDs, and CRT devices. Closely comparable to Impulse Dynamics in size, German commercial footprint (Impulse Dynamics Germany GmbH), and focus on CRM device innovation; CEO Spees is a former Biotronik SVP.
- CVRx: US-listed developer of neuromodulation devices (BAROSTIM) for heart failure — a directly comparable, novel-mechanism HF device therapy targeting an overlapping symptomatic HF patient population. Closest public-market analog in mechanism novelty and commercial stage.
- Inspire Medical Systems: Public implantable medical device company (NYSE: INSP) commercializing neurostimulation therapy for obstructive sleep apnea. Highly comparable in business model — single-platform implantable therapeutic device, direct-to-physician sales, payer-driven reimbursement — and shares Impulse Dynamics' incoming CFO.
Emerging players
- EBR Systems: Developer of the WiSE cardiac stimulation system for wireless CRT. Emerging peer in novel-mechanism heart failure device therapy targeting a similar refractory HF patient population.
- Cardiac Dimensions: Developer of the Carillon mitral contour system for functional mitral regurgitation in heart failure. Comparable as a private, venture-backed structural heart / HF device company at a similar commercial stage.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Impulse Dynamics social profiles
Digital presenceImpulse Dynamics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Impulse Dynamics leadership team
Management profileNumber of profiles
Profiles10 records
Impulse Dynamics funding detail
Funding detailFunding overview
Funding rounds10 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Impulse Dynamics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Impulse Dynamics
What does Impulse Dynamics do?
Impulse Dynamics develops, manufactures, and commercializes the Optimizer Smart Mini implantable pulse generator, which delivers proprietary Cardiac Contractility Modulation (CCM) therapy to improve symptoms and quality of life in NYHA Class III heart failure patients who are not candidates for cardiac resynchronization therapy. The system is sold to hospitals and trained cardiac electrophysiologists and is supported by external chargers (Vesta, Guardio) and programmers, plus physician training and reimbursement support services.
Is Impulse Dynamics a public or private company?
Impulse Dynamics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Impulse Dynamics founded?
Impulse Dynamics was founded in 1998. It employs 101 to 250 people.
Where is Impulse Dynamics based?
Impulse Dynamics is headquartered in Marlton, United States, in the North America region.
How does Impulse Dynamics make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are provider Support Services.
Who are Impulse Dynamics's main competitors?
Broad incumbents on record are Medtronic, Abbott, Boston Scientific, Edwards Lifesciences and ZOLL Medical. Direct peers are Biotronik, CVRx and Inspire Medical Systems. Emerging players are EBR Systems and Cardiac Dimensions.
Does Impulse Dynamics have an API?
No public API is recorded for Impulse Dynamics.
What industry is Impulse Dynamics in?
Impulse Dynamics's product category is Implantable Cardiac Devices / Cardiac Rhythm Management. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT). Its NAICS code is 334510 and its SIC code is 3845.